Biotech Firm HilleVax Prices US$200 Million IPO

Biopharmaceutical company HilleVax, Inc. (Nasdaq: HLVX) began trading on the Nasdaq Global Select Market on Friday. The firm’s initial public offering is looking to raise US$200.0 million and is expected to close on May 3, 2022.

The offering consists of 11.8 million common shares selling at US$17.00 per share.

J.P. Morgan, SVB Securities, Stifel, and Guggenheim Securities act as the joint bookrunners for the said offering. The underwriters were granted a 30-day over-allotment option to purchase additional 1,764,750 shares at the same IPO price.

The Boston-based biotech company is focused on developing and commercializing novel vaccines. Its lead candidate, virus-like particle-based vaccine HIL-214, is being developed as a potential prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Venture Capital-Backed SPAC Banner Acquisition Eyes US$150 Million IPO

Special purpose acquisition company Banner Acquisition Corp. (Nasdaq: BNNRU) started trading publicly yesterday on the...

Thursday, September 9, 2021, 12:44:00 PM

Shein Files For IPO, Recently Valued At $66 Billion

Shein, the globally recognized online fashion company founded in China, has confidentially filed for an...

Tuesday, November 28, 2023, 07:44:12 AM

RAW Rolling Papers Founder Josh Kesselman Eyes Unique IPO With QR Code Shares

Josh Kesselman, the founder and CEO of RAW Rolling Papers, has unveiled an unconventional vision...

Tuesday, June 11, 2024, 01:20:00 PM

Jeb Bush-Chaired Healthcare SPAC Jackson Acquisition Prices US$200 Million IPO

Special purpose acquisition company Jackson Acquisition Company (NYSE: RJAC.U) went public today on the New...

Thursday, December 9, 2021, 02:17:00 PM

LNG Firm Excelerate Energy Launches IPO

Liquefied natural gas company Excelerate Energy is looking to go public on the New York...

Tuesday, April 5, 2022, 02:21:00 PM